VanEck Biotech ETF Price & Performance (BBH)

Short interest in the VanEck Semiconductor ETF (SMH) fell by over 7% in April, now at 13.15% of the float. This decline suggests improving sentiment among investors after a period of heavy skepticism, even as the ETF continues to trade near all-time highs amid volatile sector dynamics.12

Recent trading activity shows large investors both buying and selling VanEck Biotech ETF (BBH) shares, with institutional ownership at 32%. The fund’s price has fluctuated between $135 and $183 in the past year, reflecting ongoing uncertainty and shifting confidence in the biotech sector.34

Biopharma ETFs experienced sharp swings last week, with some funds tumbling as much as 13% before rebounding. The Direxion Daily S&P Biotech Bull 3X Shares surged 21% intraday, while other major funds posted gains between 2.8% and 11% by week’s end, highlighting persistent volatility tied to tariff headlines.56